タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
The effect of mecobalamin on the regenerating process of myelinated fibers in ex-perimental toxic neuropathy induced by antituberculous drug ethambutol was studied.<BR>Seven rats were given 300mg/kg of ethambutol orally every day for nine months. Then they were divided into two groups. Three rats were administered 1, 000μg/kg of mecobalamin intramuscularly three times a week for the following four months (ex-perimental group). The other four were kept untreated for the same period (EB con-trol group). As untreated controls, four normally fed rats of the same age were also examined.<BR>All rats were sacrificed by perfusion with 2% glutaraldehyde solution. Sciatic nerves at midthigh level and tibial nerves at ankle level were removed and examined by teased-fiber method.<BR>The frequency of myelinated fibers showing axonal degeneration with linear rows of myelin ovoids was not different among experimental, EB control and untreated con-trol groups. However, the frequency of fibers showing regeneration after axonal de-generation was significantly higher in both sciatic and tibial nerves of the ex-perimental group than of the EB control group (p<0.02 and p<0.01) and untreated control group (p<0.001). These fibers had uniformly very short internodal lengths, all of which were less than half of the expected length judging from the standard re-gression line between nerve fiber diameter and internodal length.<BR>The result suggested that mecobalamin has a promoting role in the regeneration af-ter axonal degeneration in experimental ethambutol neuropathy.
- 一般社団法人 日本臨床薬理学会の論文
著者
関連論文
- Duchenne 型筋ジストロフィー症の運動機能障害進展過程の分析 : 罹病期間との関連から
- 2. Duchenne 型筋ジストロフィーの運動機能障害伸展過程の分析(その他の神経・筋疾患)(第20回日本リハビリテーション医学会総会)
- Duchenne 型筋ジストロフィー症の運動機能障害進展過程の分析
- 節性脱髄の非対称性進展過程について--ギランバレ-症候群および実験的鉛中毒の検討から
- PS104.Duchenne型筋ジストロフィー症の運動機能進展過程への運動年齢評価法の適用について(リウマチ・ADL)(第19回日本リハビリテーション医学会総会)
- アレルギ-性根神経炎における脱髄過程 (第21回日本神経学会総会(1980)) -- (末梢神経の脱髄をめぐって)
- 成人型acid maltase欠損症の同胞例
- ニュ-ロパチ-における神経障害の過程 (第19回日本神経学会総会) -- (ニュ-ロパチ-の成因をめぐって(シンポジウム))
- Pallido-nigral degeneration--L-DOPA が無効であった Parkinson 症候群の1例
- 末梢神経障害における有髄線維の量的変化とその意義-2-SMONについて
- 老年で発症した多発性硬化症の1剖検例
- 末梢神経障害における有髄線維の量的変化とその意義--I.Ethambutol NeuropathyとDiabetic Neuropathyについて
- ときほぐし線維法による末梢神経病変の研究 神経線維直径とRanvier絞輪間距離の相関関係の検討
- 実験的Ethambutol neuropathyの病理組織学的研究
- ときほぐし線維法による末消神経病変の研究
- 生検末梢神経の病理組織学的研究
- 2. 末梢神経障害 : 2-(1) 末梢神経障害における形態と機能の関連
- 201Tlによる心筋および骨格筋病変の核医学的検討
- Postprandial hypotensionsyncope in Shy-Drager syndrome and its treatment with oral L-DOPS.
- Effectiveness and safety of oral long-term administration of thyrotropin releasing hormone for spinocerebellar degeneration.
- タイトル無し
- タイトル無し
- Symposium on neuropeptides: basic and clinical aspects. Spinocerebellar degeneration and neuropeptides.
- 慢性経過をたどるニューロパチー
- Human T-lymphotropic virous type-I (HTLV-I) associated myelopathy における自律神経機能